Latest article
ADOCIA Presents Medical Outcomes on M1Pram on the 14th Worldwide Convention on Superior Applied...
Lyon, France - (BUSINESS WIRE) - Regulatory news:
ADOCIA (Euronext Paris: FR0011184241 - ADOC), a clinical-stage biopharmaceutical...
Insulin capsule might enhance wellbeing of individuals with diabetes
A groundbreaking...